Gene therapy and bone marrow transplant alleviate ultra-rare genetic disease symptoms
In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...
EurekAlert!8d
JAX researchers alleviate symptoms of ultra-rare genetic disease
In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches -- gene therapy ...
pharmaphorum1d
MSD leaps on FDA approval of PAH drug sotatercept
MSD’s sotatercept has become the first FDA ... leading to a better understanding of PAH and the development of a medicine in a novel treatment pathway that expands options for the patient ...
pharmaphorum3mon
Gilead, MSD say HIV combo could be weekly, oral HIV drug
MSD was originally developing a much higher ... and has announced efforts to improve access to a new, highly effective medicine.
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis
Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final ...
Hosted on MSN1mon
UK MHRA approves MSD’s pulmonary arterial hypertension therapy
MSD has received the UK Medicines and Healthcare ... We’re assured that the appropriate regulatory standards for the approval of this medicine have been met. As with all products, we will ...
The Irish Times1mon
Drug giant MSD buys Wuxi’s Irish vaccines plant in €500m deal
Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 ...
The Daily Mirror1mon
NMRA, SPC, SPMC, MSD must take responsibility of continuous supply of quality medicines: Minister
Colombo, December 25 (Daily Mirror)- Stressing the need to resolve issues in the supply of medicines soon, Health Minister Dr. Nalinda Jayatissa said the National Medicine Regulatory Authority ...